OXFORD IMMUNOTEC GLOBAL PLC's ticker is OXFD and the CUSIP is G6855A103. A total of 77 filers reported holding OXFORD IMMUNOTEC GLOBAL PLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $39,129,000 | +90.6% | 2,240,421 | +27.7% | 14.11% | +132.5% |
| Q3 2020 | $20,527,000 | +13.0% | 1,754,465 | +25.6% | 6.07% | +509.4% |
| Q2 2020 | $18,158,000 | +15.6% | 1,396,795 | -17.6% | 1.00% | -86.0% |
| Q1 2020 | $15,704,000 | -22.3% | 1,695,888 | +39.2% | 7.12% | +11.7% |
| Q4 2019 | $20,219,000 | +22.9% | 1,218,029 | +23.1% | 6.37% | +7.9% |
| Q3 2019 | $16,454,000 | +90.0% | 989,436 | +57.2% | 5.90% | +73.0% |
| Q2 2019 | $8,658,000 | +389.7% | 629,236 | +513.3% | 3.41% | +388.3% |
| Q1 2019 | $1,768,000 | -70.0% | 102,593 | -77.8% | 0.70% | -77.6% |
| Q4 2018 | $5,895,000 | +23.0% | 461,234 | +56.2% | 3.12% | +46.2% |
| Q3 2018 | $4,792,000 | +137.0% | 295,229 | +88.2% | 2.13% | +143.1% |
| Q2 2018 | $2,022,000 | -1.7% | 156,869 | -5.0% | 0.88% | +14.2% |
| Q1 2018 | $2,056,000 | -74.2% | 165,169 | -71.0% | 0.77% | -68.5% |
| Q4 2017 | $7,969,000 | -35.2% | 570,425 | -22.0% | 2.44% | -34.6% |
| Q3 2017 | $12,289,000 | -2.7% | 731,509 | -2.5% | 3.72% | +4.3% |
| Q2 2017 | $12,624,000 | +42.7% | 750,534 | +31.4% | 3.57% | +25.5% |
| Q1 2017 | $8,844,000 | +3585.0% | 570,971 | +3456.1% | 2.84% | +2772.7% |
| Q4 2016 | $240,000 | -82.9% | 16,056 | -85.6% | 0.10% | -81.0% |
| Q3 2016 | $1,402,000 | – | 111,655 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|